Document is current
Any future updates will be listed below
-
Authors
Crist, McKenzie https://orcid.org/0000-0001-9271-0322
Yaniv, Benyamin
Palackdharry, Sarah
Lehn, Maria A
Medvedovic, Mario
Stone, Timothy https://orcid.org/0000-0001-9412-2743
Gulati, Shuchi https://orcid.org/0000-0001-6793-9694
Karivedu, Vidhya
Borchers, Michael
Fuhrman, Bethany
Crago, Audrey
Curry, Joseph
Martinez-Outschoorn, Ubaldo
Takiar, Vinita https://orcid.org/0000-0002-2499-3516
Wise-Draper, Trisha M
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02325401 at ClinicalTrials.govnct02325401 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study
https://doi.org/10.1016/j.ijrobp.2015.11.007
nct02083692 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study
https://doi.org/10.1016/j.ijrobp.2015.11.007
nct02325401 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
599 Impact of metformin on immune activity in head and neck squamous cell carcinoma (HNSCC)
https://doi.org/10.1136/jitc-2024-sitc2024.0599
nct02083692 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study
https://doi.org/10.1016/j.ijrobp.2015.11.007
nct02083692 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
599 Impact of metformin on immune activity in head and neck squamous cell carcinoma (HNSCC)
https://doi.org/10.1136/jitc-2024-sitc2024.0599
nct02325401 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
599 Impact of metformin on immune activity in head and neck squamous cell carcinoma (HNSCC)
https://doi.org/10.1136/jitc-2024-sitc2024.0599
nct02325401 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study
https://doi.org/10.1016/j.ijrobp.2015.11.007
nct02083692 at ClinicalTrials.govDocuments that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study
https://doi.org/10.1016/j.ijrobp.2015.11.007
Documents that mention this clinical trial
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
https://doi.org/10.1136/jitc-2022-005632
599 Impact of metformin on immune activity in head and neck squamous cell carcinoma (HNSCC)
https://doi.org/10.1136/jitc-2024-sitc2024.0599
-
Funding
Funding for this research was provided by:
Brandon C. Gromada Head and Neck Cancer Foundation (N/A)
Clinical Trials Office (N/A)
National Institutes of Health (RSG-19-111-01-CCE)
National Institutes of Health (TR001426)
the United States Dept. of Veterans Affairs, Biomedical Laboratory Research and Development (IK2 BX004360)
American Cancer Society (RSG-19-111-01-CCE)
SSF (84070)
- License Information
